Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Martine Gioud-Paquet"'
Autor:
Douglas Patrick Ross, Evelyn J. Ellis-Grosse, Tiit Vaasna, Martine Gioud-Paquet, F. J. Maritz, Juri Teras, Johannes Breedt, Janis Gardovskis, Nathalie Dartois, Evan Loh
In a randomized, double-blind, controlled trial, 546 patients with complicated skin and skin structure infections received tigecycline 100 mg/day (a 100-mg initial dose and then 50 mg intravenously twice daily) or the combination of vancomycin 2 g/da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5707e63f0ca67fcaf2ad02da65ba08
https://europepmc.org/articles/PMC1280174/
https://europepmc.org/articles/PMC1280174/
Autor:
Karine Rutault, David W. Holt, Josep M. Campistol, Martine Gioud-Paquet, S. Epstein, James T. Burke
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 18(9)
Sirolimus is a new immunosuppressive agent used as treatment to prevent acute renal allograft rejection. One of the complications of renal transplantation and subsequent long-term immunosuppression is bone loss associated with osteoporosis and conseq
Autor:
Pierre Daloze, Martine Gioud-Paquet, Rainer Oberbauer, James T. Burke, John F. Neylan, Joseph Scarola, Henri Kreis, Josep M. Campistol, Yves Brault, Francesco Paolo Schena, Timothy H. Mathew
Publikováno v:
Journal of the American Society of Nephrology : JASN. 15(3)
Graft function at 6 or 12 mo is positively correlated with renal transplant survival. The 36-mo results of a study that tested whether withdrawing cyclosporine (CsA) from a sirolimus (SRL)-CsA-steroid (ST) regimen would affect renal graft survival ar
Publikováno v:
The Lancet. 326:554